Consistent with this notion, genetic variants influencing the threshold of immune activation were found to be associated with patient age at diagnosis and risk of relapse, suggesting that the IL10 and TLR3 pathways contribute to the pathogenesis of ALK-positive ALCL. The gene discussed is TLR3; the disease is anaplastic large cell lymphoma.